• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶-抗凝血酶复合物浓度作为全髋关节置换术和全膝关节置换术后深静脉血栓形成的早期预测指标。

Thrombin antithrombin complex concentration as an early predictor of deep vein thrombosis after total hip arthroplasty and total knee arthroplasty.

机构信息

Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, Guangdong, China.

Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518000, Guangdong, China.

出版信息

BMC Musculoskelet Disord. 2022 Jun 14;23(1):574. doi: 10.1186/s12891-022-05532-1.

DOI:10.1186/s12891-022-05532-1
PMID:35701797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9195246/
Abstract

AIM

Early predictive markers of venous thromboembolism (VTE) after total hip arthroplasty (THA)/total knee arthroplasty (TKA) remain unclear. Our study identified early predictive markers for VTE after THA/TKA.

METHODS

A single-institution retrospective review study was conducted between May 2020 and April 2022 (n = 256). All patients underwent Doppler ultrasounds exam in preoperation and seventh day after surgery. Deep vein thrombosis (DVT) was defined by Doppler ultrasound of the lower extremities, which revealed thrombosis. Thrombin-antithrombin complex (TAT), thrombomodulin (TM), and plasmin-antiplasmin complex (PIC) concentration were tested from each patient's preoperative and postoperative days 1, 4, 7, 14. These values were then accessed via receiver operating characteristic (ROC) curve analysis and further quantified the level of this risk by concentration.

RESULTS

On postoperative day 1 (pod-1), all patients' TAT and PIC concentrations were significantly higher than those preoperatively (p < 0.05). The levels of TAT and PIC in patients in the DVT group on pod-1 were significantly higher than those in the non-DVT group (p < 0.05). At pod-1, the TAT concentration for DVT patients was 49.47 ng/mL compared to 20.70 ng/mL for non-DVT patients, PIC was 3.72μg/mL compared to 1.65μg/mL. ROC curve analysis demonstrated that a TAT concentration of 24.3 ng/mL had a sensitivity of 87.9% and a specificity of 69.1%.

CONCLUSION

TAT levels on pod-1 may predict DVT early after THA/TKA, which makes it possible for early intervention to decrease the incidence of DVT.

摘要

目的

全髋关节置换术(THA)/全膝关节置换术(TKA)后静脉血栓栓塞症(VTE)的早期预测标志物仍不清楚。本研究旨在确定 THA/TKA 后 VTE 的早期预测标志物。

方法

这是一项 2020 年 5 月至 2022 年 4 月在单机构进行的回顾性研究(n=256)。所有患者在术前和术后第 7 天均接受了下肢多普勒超声检查。下肢深静脉血栓形成(DVT)通过下肢多普勒超声检查发现血栓来定义。在术前和术后第 1、4、7、14 天,检测每位患者的凝血酶-抗凝血酶复合物(TAT)、血栓调节蛋白(TM)和纤溶酶-抗纤溶酶复合物(PIC)浓度。然后通过接收者操作特征(ROC)曲线分析评估这些值,并通过浓度进一步量化这种风险的水平。

结果

术后第 1 天(pod-1),所有患者的 TAT 和 PIC 浓度均明显高于术前(p<0.05)。DVT 组患者在 pod-1 的 TAT 和 PIC 水平明显高于非 DVT 组(p<0.05)。在 pod-1,DVT 患者的 TAT 浓度为 49.47ng/mL,而非 DVT 患者为 20.70ng/mL,PIC 浓度分别为 3.72μg/mL 和 1.65μg/mL。ROC 曲线分析表明,TAT 浓度为 24.3ng/mL 时,其敏感性为 87.9%,特异性为 69.1%。

结论

THA/TKA 后 pod-1 的 TAT 水平可能早期预测 DVT,这使得早期干预降低 DVT 的发生率成为可能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5476/9195246/b9b7b4adec59/12891_2022_5532_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5476/9195246/25b10e78aeb9/12891_2022_5532_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5476/9195246/0810ce2c899c/12891_2022_5532_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5476/9195246/b9b7b4adec59/12891_2022_5532_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5476/9195246/25b10e78aeb9/12891_2022_5532_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5476/9195246/0810ce2c899c/12891_2022_5532_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5476/9195246/b9b7b4adec59/12891_2022_5532_Fig3_HTML.jpg

相似文献

1
Thrombin antithrombin complex concentration as an early predictor of deep vein thrombosis after total hip arthroplasty and total knee arthroplasty.凝血酶-抗凝血酶复合物浓度作为全髋关节置换术和全膝关节置换术后深静脉血栓形成的早期预测指标。
BMC Musculoskelet Disord. 2022 Jun 14;23(1):574. doi: 10.1186/s12891-022-05532-1.
2
Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.Xa 因子抑制剂和直接凝血酶抑制剂与低分子肝素在全髋关节或全膝关节置换术后预防血栓形成的比较:系统评价和荟萃分析。
J Arthroplasty. 2019 Apr;34(4):789-800.e6. doi: 10.1016/j.arth.2018.11.029. Epub 2018 Dec 1.
3
Incidence and preventive treatment for deep vein thrombosis with our own preventive protocol in total hip and knee arthroplasty.全髋关节和膝关节置换术中应用我们自己的预防方案的深静脉血栓形成发生率及预防治疗。
PLoS One. 2024 Jan 17;19(1):e0293821. doi: 10.1371/journal.pone.0293821. eCollection 2024.
4
Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients.凝血和纤溶标志物对预测全关节置换术后静脉血栓栓塞的临床影响。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619877458. doi: 10.1177/1076029619877458.
5
Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.凝血酶-抗凝血酶复合物、纤溶酶-α2纤溶酶抑制物复合物、血栓调节蛋白及纤溶酶原激活物抑制物-1在恶性肿瘤合并静脉血栓患者中的诊断及预后价值
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620971041. doi: 10.1177/1076029620971041.
6
Occult Left Common Iliac Vein Compression Increases Postoperative Venous Thromboembolism Risk Following Total Hip Arthroplasty.隐匿性左髂总静脉受压增加全髋关节置换术后静脉血栓栓塞风险。
J Arthroplasty. 2019 Feb;34(2):375-378. doi: 10.1016/j.arth.2018.10.024. Epub 2018 Oct 29.
7
Have Venous Thromboembolism Rates Decreased in Total Hip and Knee Arthroplasty?全髋关节和膝关节置换术后静脉血栓栓塞发生率是否降低?
J Arthroplasty. 2020 Jan;35(1):259-264. doi: 10.1016/j.arth.2019.08.049. Epub 2019 Aug 29.
8
Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.纤溶酶原激活物抑制剂-1、凝血酶-抗凝血酶复合物和凝血酶原片段 F1+2 对 TKA 后静脉血栓栓塞的诊断价值高于 D-二聚体。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221097383. doi: 10.1177/10760296221097383.
9
Value of thrombin-antithrombin III complexes in major orthopedic surgery: relation to the onset of venous thromboembolism.凝血酶 - 抗凝血酶III复合物在大型骨科手术中的价值:与静脉血栓栓塞症发病的关系
Clin Appl Thromb Hemost. 1999 Oct;5(4):228-31. doi: 10.1177/107602969900500404.
10
Risk factors for venous thromboembolism in patients with diabetes undergoing joint arthroplasty.糖尿病患者行关节置换术后静脉血栓栓塞症的风险因素。
BMC Musculoskelet Disord. 2021 Jul 6;22(1):608. doi: 10.1186/s12891-021-04453-9.

引用本文的文献

1
Management of Venous Thromboembolism After Hip and Knee Arthroplasty.髋关节和膝关节置换术后静脉血栓栓塞的管理
J Orthop Sports Med. 2025;7(3):311-327. doi: 10.26502/josm.511500210. Epub 2025 Jul 7.
2
A retrospective cohort analysis of plasma TAT level trends and adverse pregnancy outcomes in early pregnancy patients with newly diagnosed VTE.对新诊断为静脉血栓栓塞症(VTE)的早孕患者血浆凝血酶 - 抗凝血酶复合物(TAT)水平趋势及不良妊娠结局的回顾性队列分析。
Thromb J. 2025 May 15;23(1):48. doi: 10.1186/s12959-025-00732-w.
3
Plasmin-Antiplasmin Complex as a New Predictive Marker of Postoperative Venous Thromboembolism in Patients with Gynecologic Malignancy.

本文引用的文献

1
Performance of age-adjusted D-dimer values for predicting DVT before the knee and hip arthroplasty.年龄校正后的D-二聚体值在预测膝关节和髋关节置换术前深静脉血栓形成方面的表现。
J Orthop Surg Res. 2021 Jan 25;16(1):82. doi: 10.1186/s13018-020-02172-w.
2
Thrombosis rates using aspirin and a compression device as multimodal prophylaxis for lower limb arthroplasty in a screened population.在经过筛选的人群中,使用阿司匹林和一种加压装置作为下肢关节置换多模式预防措施的血栓形成率。
J Clin Orthop Trauma. 2020 Mar;11(Suppl 2):S187-S191. doi: 10.1016/j.jcot.2018.10.007. Epub 2018 Oct 16.
3
Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
纤溶酶-抗纤溶酶复合物作为妇科恶性肿瘤患者术后静脉血栓栓塞的新预测标志物
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251324918. doi: 10.1177/10760296251324918. Epub 2025 Apr 13.
4
The value of thrombus markers applied in patients with respiratory failure.血栓标志物在呼吸衰竭患者中的应用价值。
J Med Biochem. 2025 Jan 24;44(1):31-45. doi: 10.5937/jomb0-50697.
5
Caprini score combined with thrombotic molecular markers for predicting DVT in patients with traumatic fractures.Caprini评分联合血栓形成分子标志物用于预测创伤性骨折患者的深静脉血栓形成
Sci Rep. 2025 Jan 13;15(1):1847. doi: 10.1038/s41598-025-85941-z.
6
Bivalirudin anticoagulation for an infant with heparin resistance on ECMO: A case report.在 ECMO 上对肝素抵抗婴儿使用比伐卢定抗凝:一例报告。
Medicine (Baltimore). 2024 Oct 11;103(41):e39357. doi: 10.1097/MD.0000000000039357.
7
Didang decoction attenuates cancer-associated thrombosis by inhibiting PAD4-dependent NET formation in lung cancer.抵当汤通过抑制肺癌中依赖于瓜氨酸化酶4的中性粒细胞胞外陷阱形成来减轻癌症相关血栓形成。
Pulm Circ. 2024 Oct 9;14(4):e12454. doi: 10.1002/pul2.12454. eCollection 2024 Oct.
8
A prediction nomogram for deep venous thrombosis risk in patients undergoing primary total hip and knee arthroplasty: a retrospective study.初次全髋关节和膝关节置换术患者深静脉血栓形成风险的预测列线图:一项回顾性研究
Thromb J. 2023 Oct 12;21(1):106. doi: 10.1186/s12959-023-00538-8.
9
Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?斑秃患者静脉血栓栓塞风险标志物:有什么需要担心的吗?
Dermatol Ther (Heidelb). 2023 Aug;13(8):1847-1855. doi: 10.1007/s13555-023-00971-7. Epub 2023 Jul 9.
阿司匹林用于全髋关节和膝关节置换术后静脉血栓栓塞症预防的临床效果和安全性:随机临床试验的系统评价和荟萃分析。
JAMA Intern Med. 2020 Mar 1;180(3):376-384. doi: 10.1001/jamainternmed.2019.6108.
4
Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients.凝血酶生成、凝血酶-抗凝血酶复合物和凝血酶原片段 F1+2 可作为癌症患者高凝状态的生物标志物。
Thromb Res. 2020 Feb;186:80-85. doi: 10.1016/j.thromres.2019.12.018. Epub 2019 Dec 28.
5
The Predictive Value of Thromboelastogram in the Evaluation of Patients with Suspected Acute Venous Thromboembolism.血栓弹力图在疑似急性静脉血栓栓塞症患者评估中的预测价值。
Acta Haematol. 2020;143(3):272-278. doi: 10.1159/000502348. Epub 2019 Sep 11.
6
Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis.在使用利伐沙班进行血栓预防的患者中,血浆 D-二聚体对于全膝关节置换术后深静脉血栓的预测没有帮助。
J Orthop Surg Res. 2018 Jul 11;13(1):173. doi: 10.1186/s13018-018-0883-1.
7
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.髋关节或膝关节置换术后静脉血栓栓塞症的预防:阿司匹林或利伐沙班。
N Engl J Med. 2018 Feb 22;378(8):699-707. doi: 10.1056/NEJMoa1712746.
8
Early diagnosis of venous thromboembolism as a clinical primary symptom of occult cancer: Core proteins of a venous thrombus.作为隐匿性癌症临床主要症状的静脉血栓栓塞的早期诊断:静脉血栓的核心蛋白
Oncol Lett. 2017 Jul;14(1):491-496. doi: 10.3892/ol.2017.6175. Epub 2017 May 16.
9
Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study.日本社区医院接受恶性肿瘤化疗的住院患者静脉血栓栓塞症:前瞻性观察研究
BMC Cancer. 2017 May 19;17(1):351. doi: 10.1186/s12885-017-3326-1.
10
Is pre-operative assessment of coagulation profile with Thrombelastography (TEG) useful in predicting venous thromboembolism (VTE) following orthopaedic surgery?采用血栓弹力图(TEG)进行凝血指标的术前评估,对于预测骨科手术后的静脉血栓栓塞症(VTE)是否有用?
J Clin Orthop Trauma. 2016 Oct-Dec;7(Suppl 2):225-229. doi: 10.1016/j.jcot.2016.08.003. Epub 2016 Aug 24.